FDA Approval of Tisagenlecleucel: Promise and Complexities of a $475 000 Cancer Drug
- PMID: 28975266
- DOI: 10.1001/jama.2017.15218
FDA Approval of Tisagenlecleucel: Promise and Complexities of a $475 000 Cancer Drug
Similar articles
-
Monthly and Median Costs of Cancer Drugs at the Time of FDA Approval 1965-2016.J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djx173. J Natl Cancer Inst. 2017. PMID: 29117395 No abstract available.
-
Expensive cancer therapies: unintended effects.J Natl Cancer Inst. 2015 Jan 6;107(1):497. doi: 10.1093/jnci/dju497. Print 2015 Jan. J Natl Cancer Inst. 2015. PMID: 25564602 No abstract available.
-
Promising drug is victim of bad business.Nat Med. 2002 Mar;8(3):199. doi: 10.1038/nm0302-199a. Nat Med. 2002. PMID: 11875472 No abstract available.
-
Cancer drug approval in the United States, Europe, and Japan.Adv Cancer Res. 2007;96:371-91. doi: 10.1016/S0065-230X(06)96012-6. Adv Cancer Res. 2007. PMID: 17161686 Review. No abstract available.
-
Assessing tumor-related signs and symptoms to support cancer drug approval.J Biopharm Stat. 2004 Feb;14(1):5-21. doi: 10.1081/BIP-120028503. J Biopharm Stat. 2004. PMID: 15027497 Review.
Cited by
-
Allogeneic CAR-T cells for cancer immunotherapy.Immunotherapy. 2024;16(16-17):1079-1090. doi: 10.1080/1750743X.2024.2408048. Epub 2024 Oct 8. Immunotherapy. 2024. PMID: 39378059 Review.
-
Updates on the Management of Autoimmune Bullous Diseases.Indian Dermatol Online J. 2024 Aug 30;15(5):758-769. doi: 10.4103/idoj.idoj_740_23. eCollection 2024 Sep-Oct. Indian Dermatol Online J. 2024. PMID: 39359305 Free PMC article. Review.
-
New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication.MedComm (2020). 2024 May 23;5(6):e551. doi: 10.1002/mco2.551. eCollection 2024 Jun. MedComm (2020). 2024. PMID: 38783893 Free PMC article. Review.
-
Enhanced cellular therapy: revolutionizing adoptive cellular therapy.Exp Hematol Oncol. 2024 Apr 25;13(1):47. doi: 10.1186/s40164-024-00506-6. Exp Hematol Oncol. 2024. PMID: 38664743 Free PMC article. Review.
-
From neglect to spotlight: the underappreciated role of B cells in cutaneous inflammatory diseases.Front Immunol. 2024 Feb 15;15:1328785. doi: 10.3389/fimmu.2024.1328785. eCollection 2024. Front Immunol. 2024. PMID: 38426103 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
